60d FRN - published 08NOV2024

88774

Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices

and vendors, who have suffered cancers
and other designated illnesses as a
result of exposures sustained in the
production and testing of nuclear
weapons.
Executive Order 13179, issued on
December 7, 2000, delegated authorities
assigned to ‘‘the President’’ under the
Act to the Departments of Labor, Health
and Human Services, Energy and
Justice. The Department of Health and
Human Services (DHHS) was delegated
the responsibility of establishing
methods for estimating radiation doses
received by eligible claimants with
cancer applying for compensation.
NIOSH is applying the following
methods to estimate the radiation doses
of individuals applying for
compensation.
In performance of its dose
reconstruction responsibilities under
the Act, NIOSH is providing voluntary
interview opportunities to claimants (or
their survivors) individually and
providing them with the opportunity to
assist NIOSH in documenting the work
history of the employee by
characterizing the actual work tasks
performed. In addition, NIOSH and the

claimant to confirm or question the
records NIOSH has compiled. This will
also be the final opportunity for the
claimant to supplement the dose
reconstruction record.
At the conclusion of the dose
reconstruction process, the claimant
submits a form to confirm that the
claimant has no further information to
provide to NIOSH about the claim at
this time. The form notifies the claimant
that signing the form allows NIOSH to
forward a dose reconstruction report to
DOL and to the claimant, and closes the
record on data used for the dose
reconstruction. Signing this form does
not indicate that the claimant agrees
with the outcome of the dose
reconstruction. The dose reconstruction
results will be supplied to the claimant
and to the DOL, the agency that will
utilize them as one part of its
determination of whether the claimant
is eligible for compensation under the
Act.
CDC requests OMB approval for an
estimated annual 3,900 burden hours.
There is no cost to respondents other
than their time to participate.

claimant may identify incidents that
may have resulted in undocumented
radiation exposures, characterizing
radiological protection and monitoring
practices, and identify co-workers and
other witnesses as may be necessary to
confirm undocumented information. In
this process, NIOSH uses a computer
assisted telephone interview (CATI)
system, which allows interviews to be
conducted more efficiently and quickly
as opposed to a paper-based interview
instrument. Both interviews are
voluntary and failure to participate in
either or both interviews will not have
a negative effect on the claim, although
voluntary participation may assist the
claimant by adding important
information that may not be otherwise
available.
NIOSH uses the data collected in this
process to complete an individual dose
reconstruction that accounts, as fully as
possible, for the radiation dose incurred
by the employee in the line of duty for
DOE nuclear weapons production
programs. After dose reconstruction,
NIOSH also performs a brief, voluntary
final interview with the claimant to
explain the results and to allow the

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Number of
responses per
respondent

Total burden
(in hours)

Form name

Claimant ............................................
Claimant ............................................

Initial Interview .................................
Conclusion Form OCAS–1 ...............

3,600
3,600

1
1

1
5/60

3,600
300

Total ...........................................

...........................................................

........................

........................

........................

3,900

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–25987 Filed 11–7–24; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–1268; Docket No. CDC–2024–
0093]
ddrumheller on DSK120RN23PROD with NOTICES1

Number of
respondents

Type of respondents

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

VerDate Sep<11>2014

17:38 Nov 07, 2024

Jkt 265001

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Drug Overdose
Surveillance and Epidemiology (DOSE).
This data collection is designed to
facilitate rapid identification and
tracking of Emergency Department (ED)
data on eight drug overdose indicators.
DATES: CDC must receive written
comments on or before January 7, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0093 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
SUMMARY:

PO 00000

Frm 00078

Fmt 4703

Sfmt 4703

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.

FOR FURTHER INFORMATION CONTACT:

E:\FR\FM\08NON1.SGM

08NON1

88775

Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and

SUPPLEMENTARY INFORMATION:

5. Assess information collection costs.
Proposed Project
Drug Overdose Surveillance and
Epidemiology (DOSE) (OMB Control No.
0920–1268, Exp. 9/30/2025)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2022, a total of 107,941 drug
overdose deaths occurred,
corresponding to an age-adjusted rate of
32.6 per 100,000 population, quadruple
from the 2002 rate (8.2). From 2021 to
2022, the synthetic opioid-involved
death rate other than methadone
increased 4.1%, from 21.8 to 22.7 per
100,000. The psychostimulant-involved
age-adjusted death rate increased more
than 34 times, from 0.3 in 2002 to 10.4
in 2022, and two states had a significant
increase in non-fatal overdoses between
2023 and 2024. In response to the
growing severity of the opioid overdose
epidemic, the US government declared
the opioid overdose epidemic a public
health emergency (PHE) on October 26,
2017. The opioid overdose epidemic is
one of the U.S. Department of Health
and Human Services (HHS) top
priorities. In 2021, HHS expanded their
Overdose Prevention Strategy to focus
on four strategic priorities: primary
prevention, harm reduction, evidencebased treatment, and recovery support.
Drug Overdose Surveillance and
Epidemiology (DOSE) 2.0 is made
possible because the vast majority of the
participating health departments are
already rapidly collecting extensive data
on Emergency Department (ED) visits in
their jurisdiction and using these data

for the identification of public health
concerns including flu and other
respiratory illnesses, heat-related
illness, and hurricane-related health
issues. DOSE 1.0 ensured participating
jurisdictions use their data to track
suspected overdoses by providing
participating jurisdictions standardized
definitions of ED visits involving all
drug, all opioid, heroin and all
stimulant overdoses. To further advance
overdose surveillance, for DOSE 2.0,
CDC added four additional drug
indicators—fentanyl, cocaine,
methamphetamine, and benzodiazepine.
This facilitates rapid identification and
tracking of ED data on a total of eight
drug overdose indicators.
Also, no single ED surveillance
system has national coverage, but
almost all participating health
departments use one of three systems—
the NSSP BioSense System, local ED
syndromic surveillance, or ED/inpatient
hospital discharge overdose data files.
DOSE 2.0 integrates data across these
three types of ED surveillance to quickly
build a national surveillance system
while leveraging existing ED data
collection efforts. DOSE 2.0 can use data
across the three types of ED surveillance
systems because the key data
requirement is the ability to detect
change over time (e.g., data consistently
collected within the jurisdiction
overtime) and not comparability across
participating health departments (e.g.,
same data collection methods deployed
across state health departments
overtime).
CDC is requesting OMB approval for
three years with an annual estimated
burden of 655 hours. There is no cost to
respondents other than their time to
participate.

ESTIMATED ANNUALIZED BURDEN HOURS

ddrumheller on DSK120RN23PROD with NOTICES1

Type of respondent

Participating health departments sharing aggregate data
from NSSP BioSense.
Participating health departments sharing aggregate data
from local syndromic data file.
Participating health department sharing finalized ED and
inpatient hospitalization aggregate data on total ED/inpatient hospitalization visits, and metadata on a yearly
basis.
Participating health department sharing finalized aggregate data on total inpatient hospitalization visits, and
metadata on a yearly basis.
Participating health department sharing line-level ED/inpatient hospitalization discharge data (.csv) on drug
overdose-related visits (i.e., any visit with an ICD–10–
CM code between T36–T50, including all intents, encounters, underdosing, and adverse effects.

VerDate Sep<11>2014

17:38 Nov 07, 2024

Jkt 265001

Number of
respondents

Form name

PO 00000

Rapid ED overdose data
form.
Rapid ED overdose data
form.
ED and hospitalization discharge overdose data
form.
Inpatient hospitalization discharge overdose data
form.
..............................................

Frm 00079

Fmt 4703

Sfmt 4703

Responses
per
respondent

Average
burden per
response
(hours)

Total
annual
burden
(hours)

45

12

0.5

270

3

12

3

108

32

1

3

96

3

1

2

6

35

1

5

175

E:\FR\FM\08NON1.SGM

08NON1

88776

Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent

Number of
respondents

Form name

Total ............................................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–25989 Filed 11–7–24; 8:45 am]
BILLING CODE 4163–18–P

..............................................

Centers for Disease Control and
Prevention
[60Day–25–1105; Docket No. CDC–2024–
0092]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled One Health
Harmful Algal Bloom System
(OHHABS). This data collection is
designed to support the understanding
and prevention of Health Harmful Algal
Blooms (HAB) and HAB-associated
illnesses.

SUMMARY:

CDC must receive written
comments on or before January 7, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0092 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and

ddrumheller on DSK120RN23PROD with NOTICES1

DATES:

VerDate Sep<11>2014

17:38 Nov 07, 2024

Jkt 265001

Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.

To

request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,

PO 00000

Frm 00080

Fmt 4703

Sfmt 4703

Average
burden per
response
(hours)

Total
annual
burden
(hours)

I .................... I .................... I .................... I

FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Responses
per
respondent

655

electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
One Health Harmful Algal Bloom
System (OHHABS) (OMB Control No.
0920–1105, Exp. 11/30/2025)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Harmful algal blooms (HABs) are the
rapid growth of algae or cyanobacteria
(also called blue-green algae) that can
cause harm to people, animals, or the
local ecology. Algal toxins from harmful
algal blooms (HABs) include some of
the most potent natural chemicals; these
toxins can contaminate surface water
used for recreation and drinking, as well
as food sources. HABs pose a threat to
both humans and animals. Human and
animal illnesses from exposures to
HABs in fresh and marine waters have
been documented in the United States.
Animal illness may be an indicator of
bloom toxicity; thus, it is necessary to
provide a One Health approach for
reporting HAB-associated illnesses and
events.
OHHABS was approved for data
collection in 2016. The system was
launched in June 2016 along with a CDC
HAB-associated illnesses website to
provide more information for the
general public about potential illnesses
and to share resources for HAB
awareness and OHHABS with public
health partners. Since 2016, CDC has
provided technical assistance and
training to states and territories
interested in OHHABs and worked with
contractors to implement new features
for OHHABS.
CDC estimates the annualized burden
hours based on historical data of the
actual number of respondents to
OHHABS. Specifically, CDC estimates
300 annual environmental reports, 90
human reports, and 130 animal reports,
by taking the average number of reports
submitted to OHHABS during 2018–
2022. CDC had six employees use mock

E:\FR\FM\08NON1.SGM

08NON1